Lineage Cell Therapeutics Company
Develop and manufacture specialized, terminally-differentiated human cells from our pluripotent and progenitor cell starting materials.
.png)
Technology:
Regenerative Medicine
Industry:
BioEngineering
Headquarters:
Carlsbad, California, United States
Founded Date:
1990
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
1
Total Funding:
108808804
Estimated Revenue:
Less than $1M
Last Funding Date:
2021-03-08
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership